A Phase 2 Trial Testing ZP1848 in Patients With SBS

NCT02690025 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

18

Enrollment

INDUSTRY

Sponsor class

Conditions

Short Bowel Syndrome

Interventions

DRUG: ZP1848

Sponsor

Zealand Pharma

Collaborators

[object Object]